Why the study?
Does self-monitoring or self-management of oral anticoagulation therapy reduce thromboembolic events and mortality in patients on oral anticoagulation?
Does self-monitoring or self-management of oral anticoagulation therapy reduce thromboembolic events and mortality in patients on oral anticoagulation?
Self-monitoring and self-management of oral anticoagulation reduce thromboembolic events, and self-management additionally reduces all-cause mortality without increasing major hemorrhage.
No takes yet. Share an insight, caveat, or question.
May warrant implementation of self-management programs for oral anticoagulation; confirms mortality benefit distinct from self-monitoring.
Heneghan et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: